Scott, L. J. (2018). Osimertinib as first-line therapy in advanced NSCLC: A profile of its use. Drugs Ther Perspect.
Citação norma ChicagoScott, Lesley J. "Osimertinib As First-line Therapy in Advanced NSCLC: A Profile of Its Use." Drugs Ther Perspect 2018.
Citação norma MLAScott, Lesley J. "Osimertinib As First-line Therapy in Advanced NSCLC: A Profile of Its Use." Drugs Ther Perspect 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.